ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2314

Minimal Important Difference in HAQ: A Validation from Health Economic Perspectives in Patient with Rheumatoid Arthritis Using Real-World Data

Chenglong Han1, Nan Li2 and Steven Peterson3, 1Outcomes Research, Janssen Global Services, LLC, Malvern, PA, 2Janssen Global Services, LLC, Spring House, PA, 3Janssen Global Services, LLC, Malvern, PA

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Health Assessment Questionnaire and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 10, 2015

Title: Health Services Research Poster III: Patient Reported Outcomes, Patient Education and Preferences

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: A change of 0.25 in HAQ score has been considered as clinically meaningful. This study is to evaluate the clinical meaningfulness of the HAQ change from health economic perspectives in patients with rheumatoid arthritis using real-world data.

Methods: This is a retrospective cross-sectional study using data in ADELPHI Disease-Specific Program collected in 2014 (EU5 and US). Patients with clinically diagnosed rheumatoid arthritis (N=1032) were enrolled and completed self-reported outcomes measures including physical function by Health Assessment Questionnaire-disability index (HAQ-DI), employment status, work productivity by Work Productivity and Activity Impairment Questionnaire-General Health (WPAI-GH) and general health status by EQ visual analogue scale (EQ VAS). Clinical characteristics include disease activity defined by DAS28. Correlations between HAQ-DI score and other outcomes were analyzed using univariate or multiple regression analysis.

Results: The majority of patients were female (72.1%) with average age of 55 years old and disease duration of about 9 years. The mean (SD) HAQ-DI score was 0.76 (0.69) with 42.2% having a HAQ-DI score ≥ 1, indicating moderate to severe physical disability.  58% of patients were currently unemployed. Patients with a HAQ-DI score of >1.0, 77% were unemployed with a EQ VAS of 54.2, while patients with normal HAQ score of ≤0.5, 40% were unemployed with a EQ VAS of 75.6.  HAQ-DI score was significantly correlated with the unemployed in multivariate logistic regression model (p<0.001), and correlated with time lost from work (p<0.001) and general health status by EQ VAS (p<0.001) by multivariate linear regression model. After adjustment for demographic characteristics including age, gender, and disease duration, an 0.25 increase in HAQ-DI score was associated with a 30% increase in likelihood for unemployed status ( OR=1.30, 95% CI=1.22, 1.39).

Conclusion: Physical function measured by HAQ-DI is a valid measure to predict employment status and general health status in patients with rheumatoid arthritis.


Disclosure: C. Han, Johnson & Johnson Pharmaceutical Services, LLC, 3; N. Li, Janssen Global Services, LLC, 3; S. Peterson, Johnson & Johnson Pharmaceutical Services, LLC, 3.

To cite this abstract in AMA style:

Han C, Li N, Peterson S. Minimal Important Difference in HAQ: A Validation from Health Economic Perspectives in Patient with Rheumatoid Arthritis Using Real-World Data [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/minimal-important-difference-in-haq-a-validation-from-health-economic-perspectives-in-patient-with-rheumatoid-arthritis-using-real-world-data/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/minimal-important-difference-in-haq-a-validation-from-health-economic-perspectives-in-patient-with-rheumatoid-arthritis-using-real-world-data/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology